Monashee Investment Management LLC Travere Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

  • $673 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023
BUY
$17.82 - $22.89 $1.34 Million - $1.72 Million
75,000 New
75,000 $1.69 Million
Q2 2022

Aug 12, 2022
SELL
$20.94 - $30.01 $2.09 Million - $3 Million
-100,000 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$23.61 - $30.6 $2.36 Million - $3.06 Million
100,000 New
100,000 $2.58 Million

Others Institutions Holding TVTX

# of Institutions
214
Shares Held
94.3M
Call Options Held
1.2M
Put Options Held
778K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.32B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email